Smaller Copper Oxide Nanoparticles have More Biological Effects Versus Breast Cancer and Nosocomial Infections Bacteria

Document Type : Research Articles

Authors

1 Infectious Diseases Research Center, Aja University of Medical Sciences, Tehran, Iran.

2 Department of Immunology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.

3 Department of Microbiology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.

4 Department of Infectious Diseases, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.

Abstract

Background and Objectives: Despite promising successes in developing new drugs and pharmaceutical biotechnology, infectious diseases and cancer are still the principal causes of mortality and morbidity globally. Therefore, finding effective ways to deal with these pathogens and cancers is critical. Metal nanoparticles are one of the new strategies to combat bacteria and cancers. Methods: We examined the antimicrobial activity of 30 and 60 nm copper oxide nanoparticles (CuO-NPs) against Acinetobacter baumannii and Staphylococcus epidermidis bacteria responsible for nosocomial infections in standard and clinical strains and anti-cancer activity against 4T1 cell line as malignancy breast cancer cells. Synthesis of CuO-NPs was performed by a one-step reduction method and confirmed by DLS and TEM microscopy at 30 and 60 nm sizes. The antibacterial and anti-cancer activities of the nanoparticles were then investigated against the aforementioned bacteria and breast cancer. Results: Using disk, well, MIC, MBC methods, and viability/bacterial growth assay, 30 nm CuO NPs were found to have more antibacterial activity on standard and clinical strains than 60 nm CuO NPs. On the other hand, using MTT, apoptosis, and gene expression method, 30 nm nanoparticles were found to have more anti-cancer potential than 60 nm CuO NPs. Conclusions: Our findings implicate CuO-NPs to possess antimicrobial and anti-cancer effects and more significant potential in smaller sizes, suggesting their pharmaceutical and biomedical capacity.
 

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention
Volume 22, Issue 3
March 2021
Pages 893-902

Files

History

  • Receive Date: 18 January 2021
  • Revise Date: 01 March 2021
  • Accept Date: 10 March 2021

Share

How to cite

Statistics